Investigating the α-Amylase Inhibitory Effects of Adansonia digitata L.: A Comprehensive in vitro and Computational Study

ABSTRACT

Background: The study explores Adansonia digitata L.s potential in diabetes management through phytochemical and protein analyses. Materials and Methods:Eight identified phytoconstituents, comprising alkaloids, terpenes and steroids, were predicted to modulate diabetic proteins. Network analysis revealed a significant role for compound a (Kaempferol-3-O-rutinoside) in interacting with key molecules. Structural evaluations of α-amylase (PDB: 4W93) using PROCHECK and Chi1-Chi2 highlighted protein quality. Results: The molecular docking study concluded that compound a (Kaempferol-3-O-rutinoside) showedα-amylase inhibition with-8.21 kcal/mol as compared to standard drug-7.81 kcal/molacarbose. Furthermore, ADMET predictions indicated some deviations from ideal oral bioavailability for compound a, emphasizing considerations for its pharmaceutical application. The analysis also confirmed the non-toxic nature of compound a, elucidating its safety profile. The hydro alcoholic plant extract demonstrated selective inhibition of α-amylase, with IC50 values of 33.90 μg/mL. The Ethyl Acetate Fraction (EAF) exhibited an IC50 value of 29.21 μg/mL at a concentration of 50 μg/mL, compared to the standard acarbose, which had an IC50 value of 23.18 μg/mL.Conclusion: Using in vitro activity and computer-aided drug design models, the current study revealed that Adansonia digitata L. possesses potential α-amylase inhibitory characteristics.

KEYWORDS

• Anti-diabetic
• Gene Ontology
• Kaempferol-3-O-rutinoside
• Molecular Docking
• Network pharmacology

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20261273Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 60, ISSUE 1SThe Role of EPAC in the Pathogenesis of Cardiovascular Complications: A ReviewNandini Dubey, Vishal Kumar Vishwakarma, Aanchal Verma, Ahsas Goyal, Harlokesh Narayan Yadav · pp. s1–s10Research ArticleSame type: Article
• Article · VOLUME 60, ISSUE 1SGlobal Comparison of Gene and Cell Therapy Regulations: A Cross-Regional Analysis of FDA, EMA, TGA, CSFDA, DCGI, PMDA, IFDA and MFDSSeyed Heidar Mohammadi, Gholamhossein Sadeghian, Hoseein Shomali, Mohamadreza Abedi, Behrooz Jannat, Faham Khamesipour · pp. s18–s32Research ArticleSame type: Article
• Article · VOLUME 60, ISSUE 1SReview on Exploring the Combination Effect of Aldosterone along with Plasma Renin with Melatonin and Hydro-Cortisol in Diurnal RhythmMainak Pal, Masud Sk, Saheli Mandal, Dipanjan Mandal · pp. s33–s41Research ArticleSame type: Article
• Article · VOLUME 60, ISSUE 1SRegulatory Pathway for Genotoxic Impurities in Europe, US, Canada, India, Australia and UKKavyashree Kadehalli Ramegowda, Sangita Mishra, Venkatesh Madhugiri Prakash · pp. s42–s51Research ArticleSame type: Article